BioXcel Therapeutics Inc - BTAI - stock price prediction, stock price target, analyst ratings from 3 analysts

BioXcel Therapeutics Inc has a share price target of US$ 22, revenue growth forecast of -26.0%, and profit growth estimate of 21.6% for FY25, based on top 3 analyst calls.